TMCnet News
Global High Content Screening/Imaging Market (2021 to 2026) - Featuring Thermo Fisher Scientific, Yokogawa Electric and Logos Biosystems Among OthersDUBLIN, Sept. 3, 2021 /PRNewswire/ -- The "High Content Screening/Imaging: Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering.  The global market for high content screening/imaging technology should grow from $1.2 billion in 2021 to $2.3 billion by 2026 with a compound annual growth rate (CAGR) of 13.5% for the period of 2021-2026. The North American market for high content screening/imaging technology should grow from $448.2 million in 2021 to $744.1 million by 2026 with a compound annual growth rate (CAGR) of 10.7% for the period of 2021-2026.The European market for high content screening/imaging technology should grow from $336.8 million in 2021 to $674.5 million by 2026 with a compound annual growth rate (CAGR) of 14.9% for the period of 2021-2026 The current report offers a detailed picture of the high content screening/imaging market. This report highlights the current and future market potential for high content screening/imaging and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2026, as well as key market players. This report discusses the high content screening/imaging industry and its various resources. It covers the overall high content screening/imaging market including instrument or platform, consumables (reagents and kits), software and analytics, and services. The report further analyzes the market based on application, providing an analysis of drug discovery, oncology, compound profiling, molecular diagnosis, toxicity studies and neuroscience. A complete regional analysis of the market is also studied in the report. The Report Includes
The major factor contributing to the growth of the HCS/I market is the rising adoption of high content screening/imaging technology in research and development activities. The rapid adoption of HCS/Technology in the pharmaceutical industry and academic research centers indicates the importance of this information-rich screenin tool. The imaging of cell function has become increasingly important to understand the underlying functional biology associated with new therapeutic targets. Demand for improved technologies for cell research, government support, and the emergence of sophisticated informatics solutions, along with rising demand for better screening systems, is augmenting the demand for high content imaging within fully automated screening laboratories. Furthermore, technological advancements and developments in biological research and the discovery of more effective therapies for the treatment of human disease are fueling the growth of the market. HCS/I systems have continually evolved with many improvements enabled to meet user demands of greater flexibility and the growing requirements of assays involving complex cellular disease models. Increasing drug discoveryR&D globally, increasing investments, and introduction of advanced imaging instruments are the other drivers for the HCS/I market. The high cost of HCS/I instrumentation is the primary factor restraining the growth of the market. The price of machinery and instrumentation prohibits a small economy country or a research organization from purchasing HCS/I equipment. Companies are introducing more sensitive cameras and better light sources, such as LED and multicolor illumination, which are increasing the output and reliability of the system and, therefore, the overall cost of the microscopes. The price of HCS/I equipment varies from a hundred thousand to a million dollars, depending on the specifications. Inadequate infrastructure and less funding for R&D in emerging countries will also hinder the market as installation and maintenance costs are also very high and not easily feasible for emerging economies. Adoption of HCS/I in the analysis of 3D spheroids, microtissues, and phenotypic assays, are expected to impact gene editing studies based on CRISPR-Cas9 in the future. Moreover, the growing availability of perturbagen libraries and HCS/I infrastructure within academic research centers has prompted widespread interest in HCS/I applications among academic investigators. The combination of HCS/I with chemical genetics, where small organic molecules are used to study biological systems has emerged as a powerful approach for defining protein functions and dissecting signaling pathways. The rapid growth of genome-wide RNA interference (RNAi) technology to probe gene function in mammalian cell culture systematically has popularized HCS/I systems in academic research environments. Key Topics Covered: Chapter 1 Introduction Chapter 2 Summary and Highlights Chapter 3 Market and Technology Background
Chapter 4 Impact of COVID-19 Pandemic
Chapter 5 Market Dynamics
Chapter 6 Market Breakdown by Component
Chapter 7 Market Breakdown by Application
Chapter 8 Market Breakdown by End User
Chapter 9 Market Breakdown by Region
Chapter 10 Patent Review
Chapter 11 Competitive Landscape
Chapter 12 Pricing Analysis of Instruments by Major Players
Chapter 13 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/xwru5d Media Contact: For E.S.T Office Hours Call +1-917-300-0470 U.S. Fax: 646-607-1904 SOURCE Research and Markets 
|
View original content: